000 | 01989 a2200601 4500 | ||
---|---|---|---|
005 | 20250513185713.0 | ||
264 | 0 | _c19990809 | |
008 | 199908s 0 0 eng d | ||
022 | _a0028-3878 | ||
024 | 7 |
_a10.1212/wnl.53.1.139 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSimon, J H | |
245 | 0 | 0 |
_aA longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). _h[electronic resource] |
260 |
_bNeurology _cJul 1999 |
||
300 |
_a139-48 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAtrophy |
650 | 0 | 4 |
_aBrain _xpathology |
650 | 0 | 4 |
_aCerebral Ventricles _xpathology |
650 | 0 | 4 |
_aCorpus Callosum _xpathology |
650 | 0 | 4 | _aDisability Evaluation |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterferon beta-1a |
650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRegression Analysis |
700 | 1 | _aJacobs, L D | |
700 | 1 | _aCampion, M K | |
700 | 1 | _aRudick, R A | |
700 | 1 | _aCookfair, D L | |
700 | 1 | _aHerndon, R M | |
700 | 1 | _aRichert, J R | |
700 | 1 | _aSalazar, A M | |
700 | 1 | _aFischer, J S | |
700 | 1 | _aGoodkin, D E | |
700 | 1 | _aSimonian, N | |
700 | 1 | _aLajaunie, M | |
700 | 1 | _aMiller, D E | |
700 | 1 | _aWende, K | |
700 | 1 | _aMartens-Davidson, A | |
700 | 1 | _aKinkel, R P | |
700 | 1 | _aMunschauer, F E | |
700 | 1 | _aBrownscheidle, C M | |
773 | 0 |
_tNeurology _gvol. 53 _gno. 1 _gp. 139-48 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.53.1.139 _zAvailable from publisher's website |
999 |
_c10366661 _d10366661 |